Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$142.56
$139.94
$131.76
$179.60
$10.76B1.11809,316 shs600,082 shs
HemaCare Co. stock logo
HEMA
HemaCare
$25.31
+0.6%
$25.31
$8.62
$26.23
$346.52M1.4739,950 shs5,400 shs
Ontrak, Inc. stock logo
OTRK
Ontrak
$0.49
+1.0%
$1.40
$0.42
$5.53
$2.04M2.16525,284 shs9.85 million shs
Progyny, Inc. stock logo
PGNY
Progyny
$21.45
+1.0%
$21.83
$13.39
$30.42
$1.82B1.311.71 million shs605,548 shs
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$32.50
$32.50
$21.25
$32.89
$1.62B2.14820,051 shs1,170 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
-2.78%+1.62%+6.14%-7.22%+3.06%
HemaCare Co. stock logo
HEMA
HemaCare
0.00%0.00%0.00%0.00%0.00%
Ontrak, Inc. stock logo
OTRK
Ontrak
+5.05%-50.66%-66.46%-65.62%-84.21%
Progyny, Inc. stock logo
PGNY
Progyny
-3.72%+1.58%-2.12%-8.25%-25.03%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DaVita Inc. stock logo
DVA
DaVita
4.2983 of 5 stars
2.01.00.04.52.41.73.8
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
2.7381 of 5 stars
3.55.00.00.00.60.01.3
Progyny, Inc. stock logo
PGNY
Progyny
1.0977 of 5 stars
1.22.00.00.01.82.51.3
Tivity Health, Inc. stock logo
TVTY
Tivity Health
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DaVita Inc. stock logo
DVA
DaVita
2.00
Hold$164.5015.39% Upside
HemaCare Co. stock logo
HEMA
HemaCare
0.00
N/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
3.00
Buy$45.009,121.31% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.42
Hold$23.459.35% Upside
Tivity Health, Inc. stock logo
TVTY
Tivity Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest DVA, PGNY, OTRK, TVTY, and HEMA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
DaVita Inc. stock logo
DVA
DaVita
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$170.00 ➝ $164.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DaVita Inc. stock logo
DVA
DaVita
$12.82B0.84$19.14 per share7.45$4.83 per share29.52
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
$10.85M0.19N/AN/A$2.34 per share0.21
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.58$0.35 per share61.55$4.96 per share4.32
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$481.25M3.37$1.95 per share16.70$2.39 per share13.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DaVita Inc. stock logo
DVA
DaVita
$936.34M$10.0914.1311.220.986.63%176.11%4.66%8/5/2025 (Estimated)
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/A0.00N/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
-$25.49M-$15.81N/AN/AN/A-274.20%-269.88%-128.35%8/6/2025 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$54.34M$0.5737.6333.002.234.33%10.90%7.20%8/5/2025 (Estimated)
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$104.91M$1.7119.0116.411.8217.25%75.94%13.65%N/A

Latest DVA, PGNY, OTRK, TVTY, and HEMA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
Ontrak, Inc. stock logo
OTRK
Ontrak
-$1.24-$1.65-$0.41-$1.65N/A$2.02 million
5/12/2025Q1 2025
DaVita Inc. stock logo
DVA
DaVita
$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
4/14/2025Q4 2024
Ontrak, Inc. stock logo
OTRK
Ontrak
-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Tivity Health, Inc. stock logo
TVTY
Tivity Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DaVita Inc. stock logo
DVA
DaVita
23.18
1.25
1.20
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
0.54
0.72
0.72
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.39
2.39
Tivity Health, Inc. stock logo
TVTY
Tivity Health
2.97
2.47
2.47

Institutional Ownership

CompanyInstitutional Ownership
DaVita Inc. stock logo
DVA
DaVita
90.12%
HemaCare Co. stock logo
HEMA
HemaCare
N/A
Ontrak, Inc. stock logo
OTRK
Ontrak
12.95%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
91.54%

Insider Ownership

CompanyInsider Ownership
DaVita Inc. stock logo
DVA
DaVita
2.00%
HemaCare Co. stock logo
HEMA
HemaCare
26.20%
Ontrak, Inc. stock logo
OTRK
Ontrak
1.90%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
2.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
DaVita Inc. stock logo
DVA
DaVita
76,00075.50 million73.99 millionOptionable
HemaCare Co. stock logo
HEMA
HemaCare
N/A13.69 millionN/ANot Optionable
Ontrak, Inc. stock logo
OTRK
Ontrak
2504.22 million4.14 millionNo Data
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million77.66 millionOptionable
Tivity Health, Inc. stock logo
TVTY
Tivity Health
38049.93 million48.92 millionOptionable

Recent News About These Companies

Tivity Must Face Investor Claims Over Nutrisystem Acquisition
Tivity Health Denied Immediate Appeal Over Investor Class Status
10 Foods for Thyroid Health—And 3 To Avoid
Franklin-based health care company names new CEO
Tivity CEO moves to Amedisys top spot
TVTY.O
TVTY.OQ
SilverSneakers Announces 2022 Member of the Year

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DaVita stock logo

DaVita NYSE:DVA

$142.56 0.00 (0.00%)
Closing price 03:30 PM Eastern
Extended Trading
$141.45 -1.11 (-0.78%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

HemaCare stock logo

HemaCare OTCMKTS:HEMA

$25.31 +0.15 (+0.60%)
As of 01/3/2020

HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California.

Ontrak stock logo

Ontrak NASDAQ:OTRK

$0.49 +0.01 (+1.04%)
Closing price 03:59 PM Eastern
Extended Trading
$0.48 -0.01 (-2.25%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.

Progyny stock logo

Progyny NASDAQ:PGNY

$21.45 +0.21 (+0.99%)
Closing price 01:23 PM Eastern
Extended Trading
$21.16 -0.29 (-1.33%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Tivity Health stock logo

Tivity Health NASDAQ:TVTY

Tivity Health, Inc. provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine. It also provides Wisely Well brand meals designed to support individuals and caregivers who are seeking meal convenience, as well as those recovering after a hospitalization or living with chronic conditions. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was incorporated in 1981 and is headquartered in Franklin, Tennessee.